Selective Serotonin Reuptake Inhibitors (SSRIs)

Selective serotonin reuptake inhibitors are a class of antidepressants that act preferentially on the serotonin transporter, increasing serotonergic neurotransmission while having comparatively little direct affinity for the norepinephrine and dopamine transporters or for the muscarinic, histaminergic, and adrenergic receptors that contribute to the side-effect burden of older agents. Their relative selectivity is the defining feature of the class.

Definition

SSRIs are antidepressants whose principal action is selective inhibition of the presynaptic serotonin transporter (SERT), increasing the synaptic availability of serotonin with comparatively limited activity at other transporters and receptors.

Scope

This entry covers the mechanism, comparative position, and pharmacological characteristics of the SSRI class as a whole. It addresses the serotonin transporter as the molecular target and the basis for the class's tolerability profile, treating the material as pharmacology reference rather than prescribing guidance.

Core questions

• What makes SSRIs selective relative to tricyclic antidepressants?
• How does serotonin transporter inhibition relate to the delayed onset of effect?
• How does the class compare with other antidepressants in efficacy and acceptability?

Key concepts

• Serotonin transporter (SERT, SLC6A4)
• Reuptake inhibition and synaptic serotonin
• Receptor selectivity
• Delayed therapeutic onset
• Comparative tolerability

Mechanisms

SSRIs bind the serotonin transporter (SERT), a member of the SLC6 transporter family, and block reuptake of serotonin from the synaptic cleft back into the presynaptic neuron, raising serotonin availability. Because they have low affinity for the norepinephrine and dopamine transporters and for cholinergic, histaminergic, and adrenergic receptors, they avoid much of the autonomic and cardiac burden of earlier agents. The therapeutic effect develops over weeks, consistent with downstream adaptive changes rather than the immediate rise in synaptic serotonin.

Clinical relevance

SSRIs are widely studied as a first-line antidepressant class, and understanding their selective mechanism is central to appraising why their tolerability profile differs from older drugs. This description is for reference; it is not dosing, selection, or individualised treatment advice.

Evidence & guidelines

Network meta-analyses comparing many antidepressants have placed several SSRIs among agents with a favourable balance of efficacy and acceptability for acute major depression, while emphasising that differences across active drugs are generally modest.

History

SSRIs were developed to retain the serotonergic action implicated in antidepressant effect while shedding the broad receptor binding of tricyclic antidepressants. Their introduction in the late twentieth century, beginning with fluoxetine, reshaped antidepressant pharmacology toward target-selective design.

Seminal works

• kristensen-2011
• cipriani-2018

Frequently asked questions

What does 'selective' mean in selective serotonin reuptake inhibitor?

It means the drugs act preferentially at the serotonin transporter, with comparatively little direct effect on norepinephrine and dopamine transporters or on the receptors that drive many side effects of older antidepressants.

Why might an SSRI's full effect take several weeks?

Reuptake inhibition raises synaptic serotonin quickly, but the clinical effect appears to depend on slower downstream adaptations, so therapeutic benefit typically develops over weeks rather than immediately.